Sakamoto Jun | Second Department Of Internal Medicine Sapporo Medical University
スポンサーリンク
概要
関連著者
-
Sakamoto Jun
Second Department of Internal Medicine, Sapporo Medical University
-
Miura Tetsuji
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Miura Tetsuji
Second Department Of Internal Medicine Department Of Clinical Laboratory Medicine Sapporo Medical Un
-
Shimamoto Kazuaki
Second Department Of Internal Medicine (cardiovascular Medicine) Sapporo Medical University School O
-
Sakamoto Jun
Second Department Of Internal Medicine Sapporo Medical University
-
Shimamoto Kazuaki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
坂本 淳
札幌医科大学第二内科
-
MIURA Tetsuji
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Sakamoto Jun
Department Of Pharmacology School Of Medicine Sapporo Medical University
-
Miki Takayuki
Second Department of Internal Medicine, Sapporo Medical University
-
Miki Takayuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ikeda Yoshihiro
Second Department Of Internal Medicine Sapporo Medical University
-
Yano Toshiyuki
Second Department of Internal medicine, Sapporo Medical University
-
Yano Toshiyuki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Nakamura Yuichi
Second Depertment of Internal Medicine, Sapporo Medical University School of Medicine
-
Nakamura Yuichi
Second Department Of Internal Medicine Sapporo Medical University
-
Shimamoto Kazuaki
Second Department Of Internal Medicine Sapporo Medical University
-
Tanno Masaya
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Nishihara Masahiro
Second Department of Internal Medicine, Sapporo Medical University
-
Kobayashi Hironori
Second Department of Internal Medicine, Sapporo Medical University
-
Naitoh Kazuyuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Nishihara Masahiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Kobayashi Hironori
Second Department Of Internal Medicine Sapporo Medical University
-
Sakamoto Jun
Department Of Chemistry Nara University Of Education
-
Shimamoto Kazuaki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Ichikawa Yoshihiko
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Naitoh Kazuyuki
Second Department of Internal medicine, Sapporo Medical University
-
Sakamoto Jun
Department of Pharmacology, Sapporo Medical University School of Medicine
-
Tanno Masaya
Department of phamacology, Sapporo medical University School of medicine
-
Miki Takayuki
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Tanno Masaya
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Miura Tetsuji
Second Department Of Internal Medicine Sapporo Medical University
-
Miura Tetsuji
The Second Department Of Internal Medicine Sapporo Medical College
-
Horio Yoshiyuki
Department Of Pharmacology Sapporo Medical University School Of Medicine
-
Horio Yoshiyuki
Department Of Pharmacology Ii Faculty Of Medicine Osaka University
-
Horio Yoshiyuki
Department Of Pharmacology Sapporo Medical University
-
Ohhori Katsuhiko
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Horio Yoshiyuki
Department of Pharmacology, Sapporo Medical University
-
Takahashi Akari
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Ohhori Katsuhiko
Second Department Of Internal Medicine Sapporo Medical University
-
Miura Tetsuji
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Takahashi Akari
Second Department Of Medicine Sapporo Medical University School Of Medicine
-
Ishida Hideyuki
Department of Medicine, National Defense Medical College
-
Satoh Takahiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Nakano Atsushi
Second Department of Internal Medicine, Sapporo Medical University
-
Tanno Masaya
Depertment of Pharmacology, Sapporo Medical University School of Medicine
-
naitou kazuyuki
Second Department of Internal Medicine, Sapporo Medical University
-
Hishihara Masahiro
Second Department of Internal Medicine, Sapporo Medical University
-
Matsuda Eiji
Product Research Department, Chugai Pharmaceutical Co.
-
Matuda Eiji
Fuji Gotenba Research Labs, Chugai Pharmaceutical Co., Ltd.
-
Saito Keiji
Fuji Gotenba Research Labs, Chugai Pharmaceutical Co., Ltd.
-
Ohnuma Yoshito
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Matuda Eiji
Fuji Gotenba Research Labs Chugai Pharmaceutical Co. Ltd.
-
Saito Keiji
Fuji Gotenba Research Labs Chugai Pharmaceutical Co. Ltd.
-
Ishida Hideyuki
Department Of Physiology Tokai University School Of Medicine
-
Nishino Yasuhiro
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Nishino Tasuhiro
Second Department of Internal Medicine, Sapporo Medical University School of Medicine
-
Saito Keiji
Product Research Dept. Chugai Pharmaceutical Co., Ltd.
-
Nakano Atsushi
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ohnuma Yoshito
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Nishino Yasuhiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Nishino Tasuhiro
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ishida Hideyuki
Department Of Digestive Tract And General Surgery Saitama Medical Center Saitama Medical University
-
Hishihara Masahiro
Second Department Of Internal Medicine Sapporo Medical University
-
Saito Keiji
Product Research Department Chugai Pharmaceutical Co. Ltd.
-
Ishida Hideyuki
Department of Physiology, Tokai University School of Medicine
-
Ishida Hideyuki
Department of Chemistry, Faculty of Engineering Science, Osaka University
著作論文
- OE-080 Role of GSK-3 β as a Crucial Determinant of Anti-infarct Tolerance of the Myocardium(Acute myocardial infarction, basic-1 (IHD) OE14,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OE-026 Activation of ERK and Suppression of Calcineurin are Interacting Mechanisms of Cardioprotection Afforded by δ-opioid Receptor Activation(Myocardial ischemia-reperfusion, basic/clinical-1 (IHD) OE5,Oral Presentation (English),The 70th Anniversary An
- Activation of δ-Opioid Receptor Suppresses Myocardial Ischemic Injury by ERK Activation during the Early Phase of Ischemia(Acute Myocardial Infarction, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Activation of the δ-opioid Receptor Induces Phosphorylation of Connexin43 at Ser368 by PKC-ε and Reduces Myocardial Infarct Size(Myocardial Ischemia-reperfusion, Basic 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Erythropoietin Reduces Myocardial Ischemic Injury, but not Reperfusion Injury, Through Activation of the Pl3k/Akt Pathway(Myocardial Ischemia-reperfusion, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OE-080 Shedding of TNF-a by Activation of ADAM17 Contributes to Activation of Tyrosine Kinase-Mediated Pathway in Ischemic Preconditioning(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- OE-079 Suppression of Gap Junction Permeability Is a Mechanism of Cardioprotection Afforded by Activation of the Mitochondrial KATP Channel(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- OE-003 Mechanisms of Improvement in Post-infarct Ventricular Function by M-CSF in the rat : Increased Myocyte Regeneration vs. Modulation of Infarct Repair(Acute Myocardial Infarction, Basic 1 (IHD) : OE1)(Oral Presentation (English))
- Metaloprotease-Disintegrin Is Involved in Tyrosine Kinase-Mediated Signaling in Ischemic Preconditioning
- OE-312 Nuclear Localization of SIRT1, a Novel Mechanism of Cardiomyocyte Protection in Failing Hearts, is Achieved by PI3K/Akt Signaling(Heart failure, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-046 Predictors of Improvement of Exercise Capacity by Nitrates in Experimental Heart Failure(Heart failure, basic-7 (M) PJ8,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PE-601 Molecular Mechanisms of Nucleo-cytoplasmic Shuttling of SIRT1, a Histone Deacetylase, and Its Pathopysicological Roles in Cardiomyocytes(Molecular biology, myocardium-2 (M) PE106,Poster Session (English),The 70th Anniversary Annual Scientific Meeti
- PE-115 Activation of ERK Compensates Disrupted PI3K-Akt Signaling in EPO-induced Cardioprotection of Post-infarct Remodeled Hearts(Acute myocardial infarction, basic-3 (IHD) PE20,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of t
- OE-025 Cardioprotection by Erythropoietin is Associated with Translocation of Akt to Mitochondria and Its Interaction with the Adenine Nucleotide Translocase(Myocardial ischemia-reperfusion, basic/clinical-1 (IHD) OE5,Oral Presentation (English),The 70th
- Protection of Post-infarct Remodeled Myocardium by Erythropoietin is Induced by a PI3K/Akt-independent and Mitochondrial K_ Channel-dependent Mechanism(Myocardial Ischemia-reperfusion, Basic 2 (IHD), The 69th Annual Scientific Meeting of the Japanese
- Mobilization of Bone Marrow Cells Improves Ventricular Function after Myocardial Infarction by Favorable Effects on Repair in the Infarct-Noninfarct Border
- Ischemic Preconditioning (PC) Induces Dp-Regulation of GLUT4 in the Myocardium : A Possible Mechanism of Late PC against Myocardial Stunning
- Ischemic Preconditioning Enhances Engraftment of Bone Marrow-Derived Stem Cells in the Reperfused Myocardium
- Cloning and Characterization of Homolog of Sir2, a Regulator of Yeast Life Span and Senescence, in the Mouse